Literature DB >> 19467288

The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety.

Sayamwong E Hammack1, Ji-Dong Guo, Rimi Hazra, Joanna Dabrowska, Karyn M Myers, Donald G Rainnie.   

Abstract

Substantial evidence has suggested that the activity of the bed nucleus of the stria terminalis (BNST) mediates many forms of anxiety-like behavior in human and non-human animals. These data have led many investigators to suggest that abnormal processing within this nucleus may underlie anxiety disorders in humans, and effective anxiety treatments may restore normal BNST functioning. Currently some of the most effective treatments for anxiety disorders are drugs that modulate serotonin (5-HT) systems, and several decades of research have suggested that the activation of 5-HT can modulate anxiety-like behavior. Despite these facts, relatively few studies have examined how activity within the BNST is modulated by 5-HT. Here we review our own investigations using in vitro whole-cell patch-clamp electrophysiological methods on brain sections containing the BNST to determine the response of BNST neurons to exogenous 5-HT application. Our data suggest that the response of BNST neurons to 5-HT is complex, displaying both inhibitory and excitatory components, which are mediated by 5-HT(1A), 5-HT(2A), 5-HT(2C) and 5-HT(7) receptors. Moreover, we have shown that the selective activation of the inhibitory response to 5-HT reduces anxiety-like behavior, and we describe data suggesting that the activation of the excitatory response to 5-HT may be anxiogenic. We propose that in the normal state, the function of 5-HT is to dampen activity within the BNST (and consequent anxiety-like behavior) during exposure to threatening stimuli; however, we suggest that changes in the balance of the function of BNST 5-HT receptor subtypes could alter the response of BNST neurons to favor excitation and produce a pathological state of increased anxiety.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467288      PMCID: PMC2793530          DOI: 10.1016/j.pnpbp.2009.05.013

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  131 in total

1.  Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor.

Authors:  R E Grahn; M J Will; S E Hammack; S Maswood; M B McQueen; L R Watkins; S F Maier
Journal:  Brain Res       Date:  1999-04-24       Impact factor: 3.252

Review 2.  Are different parts of the extended amygdala involved in fear versus anxiety?

Authors:  M Davis
Journal:  Biol Psychiatry       Date:  1998-12-15       Impact factor: 13.382

3.  Effects of corticotropin-releasing factor on brain serotonergic activity.

Authors:  M L Price; A L Curtis; L G Kirby; R J Valentino; I Lucki
Journal:  Neuropsychopharmacology       Date:  1998-06       Impact factor: 7.853

4.  Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress.

Authors:  J F López; I Liberzon; D M Vázquez; E A Young; S J Watson
Journal:  Biol Psychiatry       Date:  1999-04-01       Impact factor: 13.382

5.  Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain.

Authors:  L W Maines; B J Keck; J E Smith; J M Lakoski
Journal:  Synapse       Date:  1999-04       Impact factor: 2.562

6.  Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat.

Authors:  V Cornea-Hébert; M Riad; C Wu; S K Singh; L Descarries
Journal:  J Comp Neurol       Date:  1999-06-28       Impact factor: 3.215

7.  Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing.

Authors:  D E Heidmann; P Szot; R Kohen; M W Hamblin
Journal:  Neuropharmacology       Date:  1998-12       Impact factor: 5.250

8.  Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners.

Authors:  A Broocks; T Meyer; A George; U Hillmer-Vogel; D Meyer; B Bandelow; G Hajak; U Bartmann; C H Gleiter; E Rüther
Journal:  Neuropsychopharmacology       Date:  1999-02       Impact factor: 7.853

Review 9.  Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load.

Authors:  J Schulkin; P W Gold; B S McEwen
Journal:  Psychoneuroendocrinology       Date:  1998-04       Impact factor: 4.905

10.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

View more
  51 in total

1.  Effects of noradrenergic alpha-2 receptor antagonism or noradrenergic lesions in the ventral bed nucleus of the stria terminalis and medial preoptic area on maternal care in female rats.

Authors:  Carl D Smith; M Allie Holschbach; Joshua Olsewicz; Joseph S Lonstein
Journal:  Psychopharmacology (Berl)       Date:  2012-05-29       Impact factor: 4.530

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

3.  Contrasting distribution of physiological cell types in different regions of the bed nucleus of the stria terminalis.

Authors:  Olga E Rodríguez-Sierra; Hjalmar K Turesson; Denis Pare
Journal:  J Neurophysiol       Date:  2013-08-07       Impact factor: 2.714

4.  Striatal-enriched protein tyrosine phosphatase-STEPs toward understanding chronic stress-induced activation of corticotrophin releasing factor neurons in the rat bed nucleus of the stria terminalis.

Authors:  Joanna Dabrowska; Rimi Hazra; Ji-Dong Guo; Chenchen Li; Sarah Dewitt; Jian Xu; Paul J Lombroso; Donald G Rainnie
Journal:  Biol Psychiatry       Date:  2013-09-05       Impact factor: 13.382

5.  Double-dissociation of the catecholaminergic modulation of synaptic transmission in the oval bed nucleus of the stria terminalis.

Authors:  Michal Krawczyk; François Georges; Robyn Sharma; Xenos Mason; Amandine Berthet; Erwan Bézard; Eric C Dumont
Journal:  J Neurophysiol       Date:  2010-11-03       Impact factor: 2.714

6.  Adolescent anabolic/androgenic steroids: Aggression and anxiety during exposure predict behavioral responding during withdrawal in Syrian hamsters (Mesocricetus auratus).

Authors:  Lesley A Ricci; Thomas R Morrison; Richard H Melloni
Journal:  Horm Behav       Date:  2013-10-11       Impact factor: 3.587

Review 7.  Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis.

Authors:  Sarah E Daniel; Donald G Rainnie
Journal:  Neuropsychopharmacology       Date:  2015-06-22       Impact factor: 7.853

Review 8.  The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse.

Authors:  Thomas Louis Kash
Journal:  Alcohol       Date:  2012-03-25       Impact factor: 2.405

9.  Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes.

Authors:  J-D Guo; S E Hammack; R Hazra; L Levita; D G Rainnie
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

10.  Presynaptic 5-HT(1B) receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis.

Authors:  J-D Guo; D G Rainnie
Journal:  Neuroscience       Date:  2009-12-03       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.